Vulva Enterprise ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  18.2% 16.7% 9.6% 9.3% 7.5%  
Credit score (0-100)  8 9 25 25 33  
Credit rating  B BB BB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  -23.4 0.8 180 46.8 36.3  
EBITDA  -23.4 -49.2 172 0.7 36.3  
EBIT  -23.4 -49.2 172 0.7 36.3  
Pre-tax profit (PTP)  -22.5 -49.1 173.6 1.9 36.9  
Net earnings  -16.7 -40.0 134.9 -0.3 24.8  
Pre-tax profit without non-rec. items  -22.5 -49.1 174 1.9 36.9  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  268 478 612 612 637  
Interest-bearing liabilities  16.4 17.1 20.7 22.4 23.3  
Balance sheet total (assets)  294 516 702 705 708  

Net Debt  10.9 -170 -77.5 -128 -152  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -23.4 0.8 180 46.8 36.3  
Gross profit growth  -560.7% 0.0% 23,581.4% -73.9% -22.4%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  294 516 702 705 708  
Balance sheet change%  -6.3% 75.5% 36.0% 0.5% 0.4%  
Added value  -23.4 -49.2 172.4 0.7 36.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -3.0 -4.0 1.0 2.0 3.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% -6,487.6% 95.9% 1.6% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -7.1% -11.7% 29.0% 0.9% 5.7%  
ROI %  -7.3% -12.1% 31.3% 1.0% 6.2%  
ROE %  -6.0% -10.7% 24.8% -0.1% 4.0%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  91.0% 92.5% 87.3% 86.8% 90.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -46.4% 344.7% -45.0% -17,579.5% -417.0%  
Gearing %  6.1% 3.6% 3.4% 3.7% 3.7%  
Net interest  0 0 0 0 0  
Financing costs %  6.8% 10.5% 15.4% 21.9% 15.1%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  3.0 7.4 3.0 3.2 4.9  
Current Ratio  11.1 13.4 7.9 7.6 10.0  
Cash and cash equivalent  5.6 186.9 98.2 150.7 174.9  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  267.5 477.5 612.4 612.1 636.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0